Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Revenue (2020 - 2025)

Agilon Health's Revenue history spans 6 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Revenue rose 3.09% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $5.9 billion, down 2.11%, while the annual FY2025 figure was $5.9 billion, 2.11% down from the prior year.
  • Revenue reached $1.6 billion in Q4 2025 per AGL's latest filing, up from $1.4 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.6 billion in Q1 2024 to a low of $150.8 million in Q4 2021.
  • Average Revenue over 5 years is $1.0 billion, with a median of $1.1 billion recorded in 2023.
  • Peak YoY movement for Revenue: crashed 53.02% in 2021, then surged 185.59% in 2023.
  • A 5-year view of Revenue shows it stood at $150.8 million in 2021, then skyrocketed by 145.18% to $369.8 million in 2022, then surged by 185.59% to $1.1 billion in 2023, then skyrocketed by 44.16% to $1.5 billion in 2024, then increased by 3.09% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Revenue are $1.6 billion (Q4 2025), $1.4 billion (Q3 2025), and $1.4 billion (Q2 2025).